We serve 2-Hydroxy-4-methylpyridine CAS:13466-41-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Contact us for information like 2-Hydroxy-4-methylpyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-hydroxy-4-methyl pyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-METHYL-2-PYRIDONE Use and application,2-hydroxy-4-methyl pyridine technical grade,usp/ep/jp grade.
Related News: The man recently traveled to Wuhan, China, and sought medical care soon after his return to Massachusetts.1,3-BIS(ISOCYANATOMETHYL)CYCLOHEXANE manufacturer Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.6-Chloronicotinic acid supplier Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.4-Bromo-2-chlorophenol vendor Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).
